Jun-Xu Li Selected Research

(5- (2- methylphenoxymethy)- 1,3- oxazolin- 2- yl) amine

7/2012

Characterization of the hypothermic effects of imidazoline I₂ receptor agonists in rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jun-Xu Li Research Topics

Disease

28	Pain (Aches) 01/2021 - 04/2011
19	Substance-Related Disorders (Drug Abuse) 01/2022 - 04/2003
8	Chronic Pain 01/2021 - 12/2014
8	Hyperalgesia 01/2019 - 03/2014
7	Cocaine-Related Disorders (Cocaine Addiction) 01/2022 - 06/2005
7	Neuralgia (Stump Neuralgia) 01/2018 - 05/2011
6	Body Weight (Weight, Body) 04/2016 - 06/2009
5	Postoperative Pain 03/2018 - 05/2014
4	Opioid-Related Disorders (Opiate Addiction) 01/2022 - 04/2012
4	Hypersensitivity (Allergy) 01/2022 - 09/2014
4	Hypothermia 10/2017 - 04/2009
3	Mental Disorders (Mental Disorder) 12/2021 - 10/2013
3	Nervous System Diseases (Neurological Disorders) 10/2017 - 10/2013
2	Tobacco Use Disorder (Nicotine Dependence) 01/2022 - 11/2018
2	Alcoholism (Alcohol Abuse) 01/2020 - 07/2014
2	Weight Loss (Weight Reduction) 04/2016 - 03/2010
1	Brain Diseases (Brain Disorder) 01/2022
1	Substance Withdrawal Syndrome (Withdrawal Symptoms) 01/2022
1	Drug-Related Side Effects and Adverse Reactions 11/2020
1	Hypertension (High Blood Pressure) 01/2020
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2020
1	Opiate Overdose 11/2019
1	Constipation 11/2019
1	Fibromyalgia (Fibrositis) 01/2019
1	Memory Disorders (Memory Loss) 05/2018
1	Alzheimer Disease (Alzheimer's Disease) 05/2018
1	Neuroinflammatory Diseases 01/2018
1	Stroke (Strokes) 10/2017
1	Osteoarthritis 10/2017
1	Neoplasms (Cancer) 12/2016
1	Chronic Disease (Chronic Diseases) 11/2016

Drug/Important Bio-Agent (IBA)

18	Opioid Analgesics (Opioids)IBA 01/2022 - 04/2011
18	Pharmaceutical PreparationsIBA 01/2022 - 04/2012
12	ImidazolinesIBA 01/2019 - 11/2011
11	LigandsIBA 12/2021 - 05/2011
10	Freund's AdjuvantIBA 01/2021 - 03/2014
9	Analgesics (Analgesic Drugs)IBA 01/2021 - 05/2011
8	2-(2-benzofuranyl)-2-imidazolineIBA 01/2018 - 10/2013
6	Trace amine-associated receptor 1IBA 01/2022 - 10/2014
6	Morphine (MS Contin)FDA LinkGeneric 01/2021 - 04/2003
5	Cocaine (Cocaine HCl)IBA 01/2017 - 06/2005
4	4- (3- fluoro- 2- methylphenyl)- 4,5- dihydrooxazol- 2- ylamineIBA 01/2022 - 10/2017
4	CR4056IBA 01/2018 - 07/2012
3	sinomenineIBA 03/2018 - 12/2014
3	QuinpiroleIBA 10/2017 - 04/2009
3	phenyzolineIBA 06/2017 - 07/2012
3	Opioid Receptors (Opioid Receptor)IBA 01/2016 - 12/2012
3	IdazoxanIBA 01/2016 - 07/2012
3	Orexin ReceptorsIBA 09/2015 - 09/2013
3	BU 224IBA 03/2014 - 07/2012
3	Serotonin (5 Hydroxytryptamine)IBA 01/2013 - 06/2009
2	Nicotine FDA Link 01/2022 - 11/2018
2	Toll-Like Receptor 4IBA 01/2022 - 01/2020
2	Dopamine (Intropin)FDA LinkGeneric 01/2022 - 01/2018
2	RO5166017IBA 12/2021 - 10/2017
2	AminesIBA 01/2020 - 07/2014
2	Adrenergic Receptors (Adrenergic Receptor)IBA 01/2020 - 07/2012
2	Imidazoline ReceptorsIBA 01/2020 - 11/2011
2	Oxycodone (Oxycontin)FDA LinkGeneric 06/2017 - 09/2015
2	vitexinIBA 12/2016 - 01/2016
2	Naltrexone (ReVia)FDA LinkGeneric 04/2016 - 04/2007
2	OrexinsIBA 09/2015 - 09/2013
2	5-chloro-3-ethyl-1H-indole-2-carboxylic acid (2-(4-piperidin-1-yl-phenyl)ethyl)amideIBA 12/2014 - 10/2014
2	CannabinoidsIBA 10/2014 - 04/2012
2	tracizolineIBA 03/2014 - 07/2012
2	Serotonin ReceptorsIBA 01/2013 - 04/2011
2	AgmatineIBA 04/2012 - 11/2011
2	8-Hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT)IBA 12/2011 - 06/2009
1	Dopamine D2 Receptors (Dopamine D2 Receptor)IBA 01/2022
1	CatecholaminesIBA 12/2021
1	Amphetamine (Amfetamine)FDA LinkGeneric 12/2021
1	RO5256390IBA 12/2021
1	(4- chlorophenyl)- (1H- imidazol- 4- ylmethyl)- isopropyl- amineIBA 12/2021
1	4- (3,4- dichlorophenyl)- 4,5- dihydrooxazol- 2- ylamineIBA 12/2021
1	Midazolam (Versed)FDA LinkGeneric 01/2021
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 11/2020
1	phenylalanyl- leucyl- phenylalanyl- glutaminyl- prolyl- glutaminyl- arginyl- phenylalaninamideIBA 11/2020
1	neuropeptide FF receptorIBA 11/2020
1	(3- chloro- 2- methylphenyl)- (4- methyl- 4,5- dihydro- 3H- pyrrol- 2- yl)amineIBA 01/2020
1	Methamphetamine (Desoxyn)FDA LinkGeneric 12/2019
1	Microfilament Proteins (Actin Binding Proteins)IBA 12/2019
1	Antidepressive Agents (Antidepressants)IBA 01/2019
1	Reserpine (Serpasil)FDA Link 01/2019
1	Protein Phosphatase 2 (Protein Phosphatase 2A)IBA 05/2018
1	HomocysteineIBA 05/2018
1	N-demethylsinomenineIBA 03/2018
1	Aminobutyrates (Aminobutyric Acid)IBA 03/2018
1	BicucullineIBA 03/2018
1	Fentanyl (Sublimaze)FDA LinkGeneric 10/2017
1	Dopamine Receptors (Dopamine Receptor)IBA 10/2017
1	CB1 Cannabinoid Receptor (CB1 Receptor)IBA 01/2017
1	KRM-II-81IBA 01/2017
1	Neuroprotective AgentsIBA 12/2016
1	AntioxidantsIBA 12/2016
1	Acetaminophen (Paracetamol)FDA LinkGeneric 01/2016
1	Drug CombinationsIBA 01/2016

Therapy/Procedure

14	Drug Therapy (Chemotherapy) 01/2022 - 04/2012
8	Therapeutics 12/2018 - 05/2012
3	Chinese Traditional Medicine (Traditional Chinese Medicine) 03/2018 - 05/2014
1	Self Administration (Administration, Self) 01/2022